Navigation Links
Simbionix and Johnson & Johnson LLC Announce Distribution Agreement at Russia and the CIS Countries
Date:4/16/2009

CLEVELAND, Ohio, April 16 /PRNewswire/ -- Simbionix, the world's leading developer of medical simulation systems, today announced an agreement with Johnson & Johnson LLC for distribution of Simbionix's simulators and related products.

Johnson & Johnson, LLC operates in Russia, Ukraine and CIS countries and is one of the subsidiaries of Johnson & Johnson.

Johnson & Johnson LLC will have exclusive rights to distribute Simbionix's line of advanced medical simulators in hospitals in the Russia and CIS countries.

"We are very excited to enter into this collaboration with Johnson & Johnson LLC to bring our advanced simulators into the Russian republic' hospitals, teaching facilities and interventional clinics," said Simbionix CEO Gary Zamler. "This agreement ushers in a new era of simulation-based training for Russia's medical community and we envision beneficial for the countries covered by the agreement, Johnson & Johnson LLC,and Simbionix."

"In the last year, Simbionix has increased its distribution channels and its exposure to the international market, "explains Mr. Doron Zilberman, Simbionix's VP of International Sales. "We see Russia as one of the leading markets in the emerging medical world; this agreement is an additional step of our on going success in the international market ..."

About Simbionix

Simbionix is a global leader in medical simulation technology. Simbionix mission is to provide state of the art, computer-assisted metrics-based surgical simulation systems, and set the standard for minimally invasive surgical training and performance.

Simbionix products provide medical experts with hands-on training in a comprehensive array of MIS procedures, including; GI Endoscopy, Endourology, percutaneous access, advanced laparoscopic procedures and Endovascular procedures. Visit http://www.simbionix.com

    Contact:

    Inbal Mazor
    VP Marketing
    Simbionix
    mailto:inbal@simbionix.com
    Tel: +972-8-9211177 ext. 222
   http://www.simbionix.com


'/>"/>
SOURCE Simbionix Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Announces FDA Filings for Paliperidone Palmitate and INVEGA(R)
2. Johnson & Johnson to Provide Webcast Presentation of Tapentadol Phase 3 Clinical Data Presented at American Pain Societys Annual Meeting
3. Prometheus and Rosetta Genomics Announce License and Collaboration Agreement
4. Premier Research Announces Milestone Investigational New Drug Application
5. PEAK Surgical Announces Completion of First PRECISE Clinical Study, Receipt of Medical Design Excellence Award for PEAK(R) Surgery System and Achievement of Over 1,000 Surgeries Using PEAK PlasmaBlade(TM)
6. Watson Announces United States Availability of RAPAFLO(TM) (silodosin), a Novel New Treatment in Benign Prostatic Hyperplasia (BPH)
7. Cephalon Announces Positive Results from a Phase Three Study of NUVIGIL in Jet Lag Disorder
8. Cynosure Announces Presentation of Favorable Results from Post-Marketing Studies of Smartlipo MPX
9. Pharmaxis Announces Milestone in Phase III Trial for Cystic Fibrosis
10. Schering-Plough Announces Results of the Early ACS Trial
11. Hyperion Therapeutics Announces Results for Phase II Study in Urea Cycle Disorders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/14/2017)... and PETACH TIKVAH, Israel , Aug. ... a leading developer of adult stem cell technologies for ... ending June 30, 2017. ... for our pivotal Phase 3 trial to investigate NurOwn ... President and Chief Executive Officer of BrainStorm. "We have ...
(Date:8/7/2017)... 7, 2017 Insightin Health, provider of ... and engagement, announced the selection of Michael ... Development, effective as of February 2017. In this role, ... strategy for our clients. Wood brings with him ... and business analytics within the healthcare industry. Wood ...
(Date:8/4/2017)... Aug. 4, 2017 The search for test ... a physician/patient consult has long been the goal of ... notable focus of the largest meeting of lab professionals ... healthcare market research firm Kalorama Information.  The firm said ... offerings or related supplies and software were at the ...
Breaking Medicine Technology:
(Date:8/17/2017)... ... 17, 2017 , ... The award-winning producers of the Innovations ... Council for Therapeutic Recreation Certification (NCTRC), slated to air nationwide, fourth quarter 2017. ... a non-profit, international organization dedicated to professional excellence for the protection of consumers ...
(Date:8/17/2017)... ... ... Georgia Urology, the largest urology practice in the Southeastern United ... in East Cobb (4800 Olde Towne Parkway, Suite 220, Marietta). , “Georgia ... Haber, Georgia Urology’s managing partner. “She brings a passionate, fresh perspective on general urology ...
(Date:8/17/2017)... ... 17, 2017 , ... The 2017 Integrated Delivery Network (IDN) ... interact with their GPO and supplier partners. This year, Winifred Hayes, RN, PhD, ... of Clinical Value Analytics, have been invited to present “Episode-based Reimbursement and the ...
(Date:8/17/2017)... ... ... In its just released 2018 Edition, The Best Lawyers in America named ... consecutive year that Hardiman and Mills have been honored and the seventh year in ... Care Law while Mills was recognized in the Administrative and Regulatory Law category. ...
(Date:8/17/2017)... Angeles, California (PRWEB) , ... August 17, 2017 , ... ... the number of South Korean men obtaining plastic surgery, largely influenced by the growing ... and beauty clinic Beverly Hills Physicians notes that standards of male appearance are changing ...
Breaking Medicine News(10 mins):